Evidence map›Paper›PMID 41080531›Full record

ArticleFrontiers in immunology2025

IFNγ regulates MR1 transcription and antigen presentation.

Megan E Huber, Emily A Larson, Taylor N Lust, Chelsea M Heisler, Melanie J Harriff

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Sorting endosomes play key roles in presentation ofbioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Megan E HuberDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, United States.
Emily A LarsonPortland Veterans Affairs Research Foundation, Portland, OR, United States.
Taylor N LustDivision of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, United States.
Chelsea M HeislerDivision of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, United States.
Melanie J HarriffDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Antigen presentation molecules play key roles in T cell immunity. Multiple complementary pathways are known to regulate classical MHC-I molecules at transcriptional, translational, and post-translational levels. Intracellular trafficking mechanisms dictating post-transcriptional regulation of MR1, the MHC-I-like molecule which restricts MAIT cells, have been an area of focus; however, little is known about Methods: Primary human airway epithelial cells (AEC) were treated with recombinant interferons or co-cultured with MAIT cell clones and antigen sources. MR1 expression was analyzed by RT-qPCR and flow cytometry. MAIT cell activity was quantified by ELISPOT. Results: Treatment of AECs with IFNβ or IFNγ variably increased MR1 transcripts, while only IFNγ significantly increased surface MR1 expression and enhanced antigen presentation to MAIT cells. The MR1 promoter contains binding motifs for interferon regulatory factor 1 (IRF1), an important MHC-I transcription factor. IRF1 knockout reduced IFNγ-stimulated MR1 transcription, surface expression, and antigen presentation. Conversely, knockout of Nod-like Receptor family CARD domain-containing 5 (NLRC5), a critical component of MHC-I transcription, did not significantly impact Conclusion: Our data support a model where IFNγ from activated MAIT cells or another source stimulates IRF1-dependent MR1 expression and antigen presentation, leading to greater MAIT cell activation. A robust MR1-dependent MAIT cell response may be beneficial for early infection responses, allowing minimal antigen stimulus to generate greater proinflammatory activity.

Indexed as

Antigen PresentationHistocompatibility Antigens Class IInterferon-gammaMinor Histocompatibility AntigensMucosal-Associated Invariant T CellsTranscription, GeneticCells, CulturedEpithelial CellsGene Expression RegulationHumansInterferon Regulatory Factor-1Promoter Regions, GeneticRespiratory MucosaHistocompatibility Antigens Class IInterferon-gammaInterferon Regulatory Factor-1IRF1 protein, humanMinor Histocompatibility AntigensMR1 protein, humanairway epithelial cellinterferon-gammaIRF1MAIT (mucosal-associated invariant T) cellMR1

Identifiers

PMID41080531
PMCPMC12510863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.